We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CSBTF market cap is 899.21M. The company's latest EPS is CHF -0.3726 and P/E is -65.51.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 2.56M | 4.04M | 13.82M | 17.99M | 33.56M |
| Operating Income | -11.39M | -11.68M | -8.77M | -13.45M | -13.19M |
| Net Income | -11.25M | -11.52M | -7.54M | -14.6M | -13.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 87.85M | 94.36M | 91.34M | 82.95M | 71.46M |
| Total Liabilities | 10M | 9.76M | 14.36M | 14.09M | 14.75M |
| Total Equity | 77.86M | 84.6M | 76.98M | 68.86M | 56.71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -10.85M | -9.24M | -5.45M | -7.35M | -8.84M |
| Investing | -118k | -220k | -374k | -400k | -326k |
| Financing | 13.13M | 17.08M | 6.08M | 3.22M | -171k |
| Market Cap | 899.21M |
| Price to Earnings Ratio | -65.51 |
| Price to Sales Ratio | 26.79 |
| Price to Cash Ratio | 63.29 |
| Price to Book Ratio | 15.86 |
| Dividend Yield | - |
| Shares Outstanding | 36.84M |
| Average Volume (1 week) | 150 |
| Average Volume (1 Month) | 848 |
| 52 Week Change | 272.67% |
| 52 Week High | 36.10 |
| 52 Week Low | 5.54 |
| Spread (Intraday) | 4.88 (18.05%) |
| Company Name | Kuros Bioscience Ltd (PK) |
| Address |
wagistrasse 25 zurich 8952 |
| Website | https://www.kurosbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
